Healthcare provider profile · identity verified

Jeffrey Stuart Hyman, MD

Internal Medicine · BROOKLYN, NY · NPI 1053317396

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	567	183
Levothyroxine Sodium	Levothyroxine Sodium	320	95
Metformin Hcl	Metformin Hcl	233	80
Amlodipine Besylate	Amlodipine Besylate	228	76
Omeprazole	Omeprazole	165	52
Metoprolol Succinate	Metoprolol Succinate	145	41
Zolpidem Tartrate	Zolpidem Tartrate	144	28
Simvastatin	Simvastatin	134	40
Glimepiride	Glimepiride	129	35
Losartan Potassium	Losartan Potassium	127	43
Tamsulosin Hcl	Tamsulosin Hcl	124	32
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	118	35
Rosuvastatin Calcium	Rosuvastatin Calcium	115	43
Gabapentin	Gabapentin	105	22
Pantoprazole Sodium	Pantoprazole Sodium	105	33
Meloxicam	Meloxicam	104	45
Alprazolam	Alprazolam	97	27
Albuterol Sulfate Hfa	Albuterol Sulfate	96	26
Hydrochlorothiazide	Hydrochlorothiazide	96	33
Furosemide	Furosemide	87	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	82	25
Metoprolol Tartrate	Metoprolol Tartrate	76	22
Sertraline Hcl	Sertraline Hcl	71	16
Bupropion Xl	Bupropion Hcl	69	19
Clopidogrel	Clopidogrel Bisulfate	68	22
Synthroid	Levothyroxine Sodium	68	19
Fluticasone Propionate	Fluticasone Propionate	64	21
Atenolol	Atenolol	63	17
Januvia	Sitagliptin Phosphate	61	12
Mupirocin	Mupirocin	60	28
Olmesartan Medoxomil	Olmesartan Medoxomil	60	20
Lisinopril	Lisinopril	59	18
Eliquis	Apixaban	56	14
Finasteride	Finasteride	56	16
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	56	18
Cefuroxime	Cefuroxime Axetil	54	42
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	49	14
Azithromycin	Azithromycin	49	41
Metformin Hcl Er	Metformin Hcl	49	15
Ezetimibe	Ezetimibe	47	14
Diclofenac Sodium	Diclofenac Sodium	45	18
Mounjaro	Tirzepatide	45	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	42	16
Ozempic	Semaglutide	40	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	39	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Ibandronate Sodium	Ibandronate Sodium	37	11
Telmisartan	Telmisartan	36	12
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Trazodone Hcl	Trazodone Hcl	34	suppressed
Levetiracetam	Levetiracetam	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	32	suppressed
Irbesartan	Irbesartan	32	suppressed
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Jardiance	Empagliflozin	31	suppressed
Famotidine	Famotidine	30	suppressed
Linzess	Linaclotide	29	suppressed
Lorazepam	Lorazepam	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Potassium Chloride	Potassium Chloride	29	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Omeprazole-Sodium Bicarbonate	Omeprazole/Sodium Bicarbonate	27	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	suppressed
Meloxicam	Meloxicam, Submicronized	24	suppressed
Carvedilol	Carvedilol	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	23	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Vascepa	Icosapent Ethyl	22	suppressed
Chlorzoxazone	Chlorzoxazone	21	suppressed
Valsartan	Valsartan	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Icosapent Ethyl	Icosapent Ethyl	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Baclofen	Baclofen	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Doxepin Hcl	Doxepin Hcl	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	17
Ibuprofen	Ibuprofen	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Naproxen	Naproxen	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Allopurinol	Allopurinol	15	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	15	14
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Diclofenac Potassium	Diclofenac Potassium	14	suppressed
Dihydroergotamine Mesylate	Dihydroergotamine Mesylate	14	suppressed
Duloxetine Hcl	Duloxetine Hcl	14	suppressed
Minoxidil	Minoxidil	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	suppressed
Ammonium Lactate	Ammonium Lactate	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Glipizide	Glipizide	13	suppressed
Ramipril	Ramipril	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Benicar	Olmesartan Medoxomil	12	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Klonopin	Clonazepam	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Lactulose	Lactulose	12	suppressed
Metformin Er Gastric	Metformin Hcl	12	suppressed
Percocet	Oxycodone Hcl/Acetaminophen	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Benicar Hct	Olmesartan/Hydrochlorothiazide	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error